BioInfra Co., Ltd. (KOSDAQ:199730)
South Korea · Delayed Price · Currency is KRW 5,280.00
0.00 (0.00%)
Last updated: Sep 19, 2025, 11:15 AM KST
BioInfra Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Operating Revenue | 24,475 | 23,833 | 30,129 | 35,427 | 30,555 | 19,610 | Upgrade |
Other Revenue | - | - | -0 | - | - | -0 | Upgrade |
| 24,475 | 23,833 | 30,129 | 35,427 | 30,555 | 19,610 | Upgrade | |
Revenue Growth (YoY) | -7.14% | -20.89% | -14.96% | 15.95% | 55.82% | 13.42% | Upgrade |
Cost of Revenue | 19,187 | 18,233 | 20,656 | 21,529 | 18,576 | 11,388 | Upgrade |
Gross Profit | 5,287 | 5,600 | 9,472 | 13,898 | 11,979 | 8,222 | Upgrade |
Selling, General & Admin | 2,828 | 2,980 | 3,051 | 3,017 | 1,586 | 1,444 | Upgrade |
Research & Development | 7,312 | 6,960 | 4,488 | 4,006 | 2,781 | 2,777 | Upgrade |
Other Operating Expenses | 135.31 | 134.44 | 101.49 | 78.18 | 25.67 | 63.97 | Upgrade |
Operating Expenses | 10,916 | 10,717 | 8,167 | 7,538 | 4,517 | 4,597 | Upgrade |
Operating Income | -5,629 | -5,117 | 1,305 | 6,360 | 7,463 | 3,625 | Upgrade |
Interest Expense | -353.05 | -376.57 | -427.3 | -369.51 | -223.13 | -131.69 | Upgrade |
Interest & Investment Income | 320.52 | 405.25 | 366.75 | 50.48 | 47.27 | 40.6 | Upgrade |
Currency Exchange Gain (Loss) | 0.6 | 0.6 | - | -55.96 | 6.76 | -15.36 | Upgrade |
Other Non Operating Income (Expenses) | -44.92 | -73.63 | 30.48 | 72.88 | -17.96 | 40.3 | Upgrade |
EBT Excluding Unusual Items | -5,706 | -5,161 | 1,275 | 6,058 | 7,276 | 3,559 | Upgrade |
Gain (Loss) on Sale of Investments | -722.03 | -714.52 | 3.33 | 24.79 | -209.88 | -0.32 | Upgrade |
Gain (Loss) on Sale of Assets | - | - | 0.05 | 903.7 | 33.04 | -0.78 | Upgrade |
Pretax Income | -6,428 | -5,876 | 1,279 | 6,987 | 7,099 | 3,557 | Upgrade |
Income Tax Expense | -1,824 | -1,900 | -723.09 | 749.37 | 864.63 | -633.65 | Upgrade |
Net Income | -4,604 | -3,976 | 2,002 | 6,237 | 6,234 | 4,191 | Upgrade |
Net Income to Common | -4,604 | -3,976 | 2,002 | 6,237 | 6,234 | 4,191 | Upgrade |
Net Income Growth | - | - | -67.91% | 0.05% | 48.75% | - | Upgrade |
Shares Outstanding (Basic) | 5 | 5 | 5 | 4 | 4 | 1 | Upgrade |
Shares Outstanding (Diluted) | 5 | 5 | 5 | 4 | 4 | 1 | Upgrade |
Shares Change (YoY) | -0.38% | 3.17% | 13.83% | -0.02% | 200.05% | -0.01% | Upgrade |
EPS (Basic) | -946.41 | -820.20 | 426.00 | 1511.00 | 1510.00 | 3046.00 | Upgrade |
EPS (Diluted) | -946.41 | -820.20 | 426.00 | 1511.00 | 1510.00 | 3046.00 | Upgrade |
EPS Growth | - | - | -71.81% | 0.07% | -50.43% | - | Upgrade |
Free Cash Flow | -1,837 | -1,071 | -2,395 | -2,107 | -7,559 | 1,902 | Upgrade |
Free Cash Flow Per Share | -377.56 | -220.97 | -509.75 | -510.36 | -1830.82 | 1382.29 | Upgrade |
Gross Margin | 21.60% | 23.50% | 31.44% | 39.23% | 39.20% | 41.93% | Upgrade |
Operating Margin | -23.00% | -21.47% | 4.33% | 17.95% | 24.42% | 18.48% | Upgrade |
Profit Margin | -18.81% | -16.68% | 6.64% | 17.61% | 20.40% | 21.37% | Upgrade |
Free Cash Flow Margin | -7.50% | -4.49% | -7.95% | -5.95% | -24.74% | 9.70% | Upgrade |
EBITDA | -2,231 | -1,801 | 3,693 | 8,340 | 8,642 | 4,566 | Upgrade |
EBITDA Margin | -9.11% | -7.56% | 12.26% | 23.54% | 28.29% | 23.28% | Upgrade |
D&A For EBITDA | 3,398 | 3,316 | 2,388 | 1,980 | 1,180 | 941.23 | Upgrade |
EBIT | -5,629 | -5,117 | 1,305 | 6,360 | 7,463 | 3,625 | Upgrade |
EBIT Margin | -23.00% | -21.47% | 4.33% | 17.95% | 24.42% | 18.48% | Upgrade |
Effective Tax Rate | - | - | - | 10.73% | 12.18% | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.